Invesco’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-81,772
| Closed | -$13.5M | – | 4099 |
|
|
2021
Q2 | $13.5M | Sell |
81,772
-539,765
| -87% | -$90.1M | ﹤0.01% | 1867 |
|
|
2021
Q1 | $95.3M | Sell |
621,537
-210,598
| -25% | -$28.6M | 0.03% | 830 |
|
|
2020
Q4 | $104M | Buy |
832,135
+15,981
| +2% | +$1.79M | 0.03% | 708 |
|
|
2020
Q3 | $82.8M | Buy |
816,154
+2,344
| +0.3% | +$239K | 0.03% | 708 |
|
|
2020
Q2 | $79.2M | Buy |
813,810
+32,892
| +4% | +$3.06M | 0.03% | 698 |
|
|
2020
Q1 | $64.8M | Sell |
780,918
-182,914
| -19% | -$17.8M | 0.03% | 681 |
|
|
2019
Q4 | $107M | Buy |
963,832
+470,694
| +95% | +$48.4M | 0.03% | 625 |
|
|
2019
Q3 | $48.9M | Sell |
493,138
-238,965
| -33% | -$23.7M | 0.01% | 1005 |
|
|
2019
Q2 | $72.6M | Buy |
732,103
+210,654
| +40% | +$20.1M | 0.02% | 834 |
|
|
2019
Q1 | $57.5M | Buy |
521,449
+2,192
| +0.4% | +$229K | 0.02% | 779 |
|
|
2018
Q4 | $47.8M | Buy |
519,257
+11,526
| +2% | +$1.17M | 0.02% | 789 |
|
|
2018
Q3 | $55.9M | Buy |
507,731
+64,671
| +15% | +$6.73M | 0.02% | 825 |
|
|
2018
Q2 | $41.4M | Buy |
443,060
+68,726
| +18% | +$5.92M | 0.01% | 913 |
|
|
2018
Q1 | $31.1M | Sell |
374,334
-7,998
| -2% | -$711K | 0.01% | 949 |
|
|
2017
Q4 | $34.8M | Buy |
382,332
+129,587
| +51% | +$10.8M | 0.01% | 930 |
|
|
2017
Q3 | $19.3M | Buy |
252,745
+205,223
| +432% | +$15.5M | 0.01% | 1214 |
|
|
2017
Q2 | $3.56M | Sell |
47,522
-26,992
| -36% | -$1.87M | ﹤0.01% | 2160 |
|
|
2017
Q1 | $4.86M | Buy |
74,514
+11,868
| +19% | +$699K | ﹤0.01% | 2005 |
|
|
2016
Q4 | $3.45M | Buy |
62,646
+24,909
| +66% | +$1.37M | ﹤0.01% | 2215 |
|
|
2016
Q3 | $2.13M | Sell |
37,737
-44,512
| -54% | -$2.18M | ﹤0.01% | 2510 |
|
|
2016
Q2 | $3.44M | Sell |
82,249
-3,385
| -4% | -$156K | ﹤0.01% | 2162 |
|
|
2016
Q1 | $3.66M | Buy |
85,634
+512
| +0.6% | +$21.6K | ﹤0.01% | 2095 |
|
|
2015
Q4 | $3.85M | Sell |
85,122
-16,531
| -16% | -$695K | ﹤0.01% | 2094 |
|
|
2015
Q3 | $3.95M | Buy |
101,653
+77,224
| +316% | +$3.09M | ﹤0.01% | 2035 |
|
|
2015
Q2 | $888K | Buy |
+24,429
| New | +$773K | ﹤0.01% | 3147 |
|
|
2015
Q1 | – | Sell |
-44,631
| Closed | -$1.08M | – | 4094 |
|
|
2014
Q4 | $1.08M | Buy |
+44,631
| New | +$1.01M | ﹤0.01% | 2926 |
|
Other funds holding PRAH
Invesco's PRAH Position: Q3 2021 in Review
Invesco sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 81,772 shares — an estimated $13.5M sold.
Invesco first reported a position in PRAH in Q4 2014 and held it in 26 quarters. The position peaked at $107M in Q4 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Invesco reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Invesco sold 81,772 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $13.5M.
- Invesco first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 26 quarters.
- Invesco's PRA Health Sciences, Inc. position peaked at $107M in Q4 2019.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Invesco's 13F filing for Q3 2021, filed 15 Nov 2021.